JERUSALEM, July 17 (Reuters) – Israel’s CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
Read more here.
JERUSALEM, July 17 (Reuters) – Israel’s CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
Read more here.
![[Kenna Security in The Enterprisers Project] Security 2020: 4 trends to watch](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
